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Summary
Transitional mutations at CpG dinucleotides account for
approximately a third of all point mutations. These mu-
tations probably arise through spontaneous deamination
of 5-methylcytosine. Studies of CpG mutation rates in
disease-linked genes, such as factor VIII and FGFR3,
have indicated that they more frequently originate in
male than in female germ cells. It has been speculated
that these sex-biased mutation rates might be a conse-
quence of sex-specific methylation differences between
the female and the male germ lines. Using the bisulfite-
based genomic-sequencing method, we investigated the
methylation status of the human factor VIII and FGFR3
genes in mature male and female germ cells. With the
exception of a single CpG, both genes were found to be
equally and highly methylated in oocytes and spermat-
ocytes. Whereas these observations strongly support the
notion that DNA methylation is the major determining
factor for recurrent CpG germ-line mutations in patients
with hemophilia and achondroplasia, the higher muta-
tion rate in the male germ line is apparently not a simple
reflection of sex-specific methylation differences.
Introduction
The involvement of cytosine methylation in the regu-
lation of gene expression and as an epigenetic modifi-
cation marking imprinted genes is well established (Bird
1987; Laird and Jaenisch 1994; Olek and Walter 1997;
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Wutz 1997). Methylated cytosines are predominantly
found within CpG dinucleotides (Bird 1980;Gruenbaum
et al. 1981). 5-Methylcytosines are prone to spontaneous
deamination on hydrolytic attack, yielding the natural
base thymine, and therefore are inherently more difficult
to repair. As a result of the hypermutability of 5-meth-
ylcytosine, CpG dinucleotides are underrepresented in
the human genome, by a factor of four to five (Schor-
deret and Gartler 1992). The remaining 5-methylcyto-
sines place a heavy mutational burden on the human
genome. Approximately 37% of all germ-line mutations
responsible for genetic diseases are localized to CpG di-
nucleotides (Cooper and Youssoufian 1988).
The parental origin of germ-line mutations is not
equally distributed between the two sexes; Haldane
(1947) first reported a higher male than female rate for
the origin of mutations in hemophilia families. Recently,
molecular identification of underlying mutations in
many diseases has amply confirmed a sex bias in germ-
line mutations. Most studies of the sex ratio for point
mutations in hemophilia A and B have shown a greater
number of mutations in males (Rosendaal et al. 1990;
Ketterling et al. 1993; Oldenburg et al. 1993; Becker et
al. 1996; Sommer and Ketterling 1996). This effect is
even more pronounced with respect to point mutations
at CpG sites (Ketterling et al. 1993), which account for
40% of all point mutations in hemophilia (Pattinson et
al. 1990). Studies of the X-linked zink-finger-protein
gene (ZFX)—and its homologous gene ZFY—on the Y
chromosome have estimated a male:female mutation ra-
tio of 6.5 (Shimmin et al. 1993). In birds, in which males
are homogametic (i.e., ZZ) and females are heteroga-
metic (i.e., WZ), a male:female mutation ratio of 5.2
was found for the Z-linked CHD gene (chromo-helicase
DNA–binding protein), compared with its homologue
on the W chromosome (Ellegren and Fridolfsson 1997).
There are three major explanations for the observed
bias in the origin of mutation: (i) If germ-line mutations
are assumed to be largely the results of replication errors,
then the higher number of mitotic cell divisions in sper-
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matocytes, relative to oocytes, might explain the higher
mutability of spermatocytes (Vogel andMotulsky 1997).
(ii) Differences in the level of CpG methylation, between
male and female germ cells, might result in sex-specific
mutation patterns (Driscol and Migeon 1990; Crow
1997; Sapienza 1996). (iii) A combination of both mech-
anisms—namely, the fixation of an elevated mutation
rate at 5-methylated CpGs, via replication, could be
responsible.
Here we present the first detailed comparison of the
methylation maps of nonclustered CpG dinucleotides
within the factor VIII and FGFR3 genes in human male
and human female germ cells. These two genes were
selected to as a means to address the correlation between
sex-specific mutation rates and the methylation status of
male and female germ cells, because they show high rates
of CpG mutation and paternal bias for the origin of
mutations. Our results for the factor VIII and FGFR3
genes provide evidence that these CpG sites are highly
methylated in both male and female germ cells.
Material and Methods
Sample Preparation
Ejaculates from 10 donors were pooled. DNA was
extracted according to the method of Gill et al. (1985):
The samples containing mature sperm cells, epithelial
cells, and lymphocytes were washed with lysis solution
containing SDS and proteinase K. The released DNA
was discarded, and the unlysed mature sperm-cell pellet
was treated with DTT, SDS, and proteinase K. DNA
from the supernatant was ethanol precipitated and dis-
solved in Tris-EDTA (TE) buffer. Nonfertilized meta-
phase I or GV-phase oocytes from women undergoing
in vitro fertilization were collected. Oocytes were puri-
fied briefly with hyaluronidase enzyme, to remove cu-
mulus cells. Residual adhering cells were removed by
repetitive pipetting in a micropipette. Purified oocytes
were stored in 1 # PBS at 20C until use. For PCR
amplification, a pool of x40 oocytes were used in each
reaction. A pool of 23 first polar bodies was obtained
by laser-assisted microdissection of the zona pellucida
and picking of the polar bodies by means of a micro-
pipette (Montag et al. 1998).
Bisulfite Modification of DNA
Modification of the oocyte DNA and of the isolated
chromosomal sperm DNA, by sodium bisulfite, was per-
formed according to the method of Olek et al. (1996).
Approximately 5 ml of oocyte pool suspended in 1 #
PBS was mixed with 2 vol of 2% low melting point
(LMP) agarose prepared in 1 # PBS. A 10-ml portion
of this mixture was pipetted into 300 ml of cold mineral
oil laid over 800 ml of lysis solution (10 mM Tris-HCl,
10 mM EDTA, 1% SDS, 20 mg proteinase K/ml). After
overnight incubation at 50C, agarose beads were
treated with para-methyl-sulfonyl-fluorid (PMSF) to in-
activate proteinase K, were washed several times with
TE buffer (pH 9), were equilibrated against EcoRI re-
striction-enzyme buffer, and were digested overnight.
DNA was denatured by equilibration against 0.3 M
NaOH and 0.1 M NaOH. Individual beads were over-
laid with mineral oil and were boiled for 15 min to
ensure complete separation of individual DNA strands.
The tube was put on ice, to resolidify the agarose beads.
Isolated sperm DNA was digested with EcoRI, was in-
cubated with 0.3 M NAOH for 15 min at 50C, and
subsequently was mixed with 2% LMP agarose to form
agarose beads.
Individual agarose beads containing sperm DNA or
oocyte DNA were incubated at 50C for 4 h in the dark,
in 100 ml of 2.5 M sodium metabisulfite, 125 mM hy-
droquinone, pH 5.0. Beads were then washed with 1 ml
of TE solution (six times, 15 min each), which was fol-
lowed by desulfonation in 500 ml of 0.2MNaOH (twice,
15 min each). The reactions were neutralized by HCl,
and the beads were washed with TE followed by a wash-
ing with double-distilled H2O.
PCR Reaction
Each PCR target region was amplified in two rounds
of PCR, by means of two nested pairs of primers, to
achieve best sensitivity and maximum specificity. All
PCRs were done in 100-ml vol containing 200 mM each
dNTP, 2.25 mM MgCl2, 50 mM KCl, 10 mM Tris-HCl
pH 8.3, 2.5 units of Taq polymerase, and 25 pmol of
each primer (table 1). PCRs were performed in a Bio-
metra Trioblock-Thermocycler, with the following pro-
gram: 94C for 5 min; 35 cycles of 92C for 45 s,
55–68C (depending on the pair of primers used; see
table 1) for 1 min 15 s, and 72C for 1 min 45 s; and
a final extension step at 72C for 10 min.
Cloning of PCR Products and DNA Sequencing
The desired PCR products were cloned in pCR II-TA
cloning vector, by means of the original TA Cloning Kit
from Invitrogen. Positive clones were selected and iden-
tified by PCR. Approximately 20 positive clones from
each region were sequenced by means of Thermo Se-
quenase and DYEnamic ET primers (-40 M13 for-
ward-labeled primer) from Amersham (ABI Prism 373
automated sequencer). Individual clones were identified
by comparison of the positions of residual (K1%) un-
modified or non-CpG methylated positions within the
individual sequences.
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Table 1
Primers Used in PCR Amplifications for Regions A–D (Factor VIII Gene) and Region E
(FGFR3 Gene)
Region and Exon
(Size; Annealing Temperature) Primer Names (Sequences)
A:
Exons 8 and 9:
External (581 bp; 60C) BiF8/9F12 (acc ttg ggt ata tta tat tgt tgt tga aga gg)
BiF8/9R12 (ctc tcc aaa ctt ttt ctt ctt acc taa cct)
Nested (506 bp; 65C) BiF8/9F13 (tgt tgt tga aga gga gga ttg gga tta tgt)
BiF8/9R13 (tat atc tcc aac ttc ccc ata aaa taa aaa tc)
Exon 9:
Nested (180 bp; 60C) BiF8/9F16 (aga agt tat aaa agt taa tat ttg aat aat gg)
BiF8/9R13: (same as above)
B:
Exon 14:
External (617 bp; 50C) BiF8/14F5 (tag taa tgg gtt ttt tgg tta ttt gga t)
BiF8/14R6 (taa aaa act act cat ccc ata atc cca a)
Nested (561 bp; 55C) BiF8/14F6 (agg gag ttt ttt tta ggg aat aga ggg a)
BiF8/14R5 (taa tcc caa aac ctc tcc act aca aca a)
C:
Exons 17 and 18:
External (616 bp; 60C) BiF8/18F14 (att tgt ttt gtt ttt tat tat ttt tga tga gat)
BiF8/18R14 (taa tca cta att ata ttc cca ata cct aaa cc)
Nested (490 bp; 62C) BiF8/18F15 (tat tga aaa tat gga aag aaa ttg tag ggt)
BiF8/18R15 (caa aca aac tca tac cta aat aaa aat tat
aca)
D:
Exon 23U:
External (570 bp; 63C) BiF8/23F3 (gta ttt tga att gtt ttt agg tga tgt tgt t)
BiF8/23R4 (ctc aaa ata act aaa aca att aat cac cct a)
Nested (460 bp; 60C) BiF8/23F4 (att atg ttg gag tag tag agt tta aat ggt t)
BiF8/23R3 (act taa cac tta cta ttt aat cac aac cca t)
Exon 23L:
External (546 bp; 63C) BiF8/23F1 (tag tta gtt att tta ttt atg gtt gag gga a)
BiF8/23R1 (att acc ctc aaa taa tac tac cta ctc cta a)
Nested (507 bp; 55C) BiF8/23F2 (tta ttt tat tta tgg ttg agg gaa gaa gga t)
BiF8/23R2 (cta taa acc ata ata aaa taa caa aac cca a)
E:
Exon 10:
External (470 bp; 60C) BiFGFR3/10F1 (ttt ttt tag ggt ttg gtt ttt tag att tat)
BiFGFR3/10R1 (aca aaa aaa act cac aca aca caa aac)
Nested (308 bp; 60C) BiFGFR3/10F2 (ggt ttt ggg tta ggg gaa ttt atg gga)
BiFGFR3/10R2 (aac aaa caa ctc aaa acc taa tat cta ctt)
Statistical Analysis
x2 Tests were applied for statistical analysis. The
equation used was as follows: 2x  (ad bc)2n/[(a
, where a and b are the numberb)(a c)(b d)(d c)]
of methylated clones at sites 1 and 2, respectively,
whereas c and d are the number of unmethylated clones
at sites 1 and 2, respectively, and n is the total number
of clones for sites 1 and 2.
Results
Using the sodium bisulfite–conversion method, we an-
alyzed the methylation rate of selected CpG dinucleo-
tides of the factor VIII and FGFR3 genes, in human
mature spermatocytes and mature oocytes. By this
method all nonmethylated cytosine nucleotides are con-
verted to uracil, whereas the methylated cytosines re-
main unconverted under the experimental condition
(Frommer et al. 1992; Olek et al. 1996). After ampli-
fication, cloning, and sequencing of PCR fragments ob-
tained from sodium bisulfite–treated chromosomal
DNA, methylation was determined by the presence of
nonconverted cytosines in the sequencing profile.
In mature spermatocytes, all of the 33 CpG sites in-
vestigated were found to be highly methylated (fig. 1).
a total of 25 CpG sites in regions A, C, and D of the
factor VIII gene, including one intronic CpG site, and
in region E of the FGFR3 gene were almost completely
methylated, with overall methylation levels of 95%–
100%. In region B of the factor VIII gene, which con-
Figure 1 Methylation profiles of clones from selected regions of the factor VIII and FGFR3 genes. Shown at the tops of the panels are the exon/intron structures of the genes, for the regions
analyzed. Exons are represented as blackened bars. Gene regions examined are labeled “A”–“E” and have been enlarged. The no. of mutations reported for each codon is indicated. Bisulfite sequences
obtained from individual cloned fragments are depicted as horizontal lines with individual CpGs represented by unblackened circles (for unmethylated) and blackened circles (for methylated).
Compilation of results for the factor VIII (A) and FGFR3 gene (B) genes is shown. The percentages of methylated clones and of unmethylated clones are listed along the line separating sperm data
and egg data.
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tains eight CpG sites, the situation is somewhat different.
All CpGs exhibit a heterogeneous and less prevalent
methylation level, 41%–82%.Methylation in this region
is not only significantly lower than that in regions A, C,
or D ( to ), but it also shows a mosaicP  .027 P ! .001
distribution on individual chromosomes. However, al-
though the distribution of methylated and nonmethy-
lated CpGs appears to be highly mosaic, all chromo-
somes show at least 40% overall methylation.
In view of the differences between regions B and D
of the factor VIII gene in spermatocyte chromosomes,
we analyzed the methylation levels of these regions and
of region E of the FGFR3 gene, in chromosomes of ma-
ture oocytes. For regions B and D, 17 and 22 individual
clones, respectively, were sequenced, which—when com-
pared with the number of oocytes used as a starting
material—represent ∼20%–25% of the chromosomes
analyzed (fig. 1). We therefore can exclude any signifi-
cant bias during PCR or cloning, toward either meth-
ylated or nonmethylated fragments. Again, regions D
and E displayed a rather homogeneous highly methyl-
ated profile on all chromosomes, whereas region B ap-
peared to be highly mosaic. When these results were
compared with those obtained for spermatocytes, 26 of
the 27 CpG sites analyzed revealed a very similar overall
methylation level, including the heterogeneously meth-
ylated region B in exon 14. Only a single CpG dinu-
cleotide at codon 1689 was significantly less methylated
in oocytes than in spermatocytes (29% vs. 77%; P 
)..003
To test whether the methylation levels analyzed in the
oocyte samples might represent differences in chromo-
somes derived from the egg versus those derived from
the first polar body, we performed a bisulfitemethylation
analysis with a pool of 23 first polar bodies. Analysis
of six clones of region E of the FGFR3 gene showed that
the CpG dinucleotides of DNA from pooled first polar
bodies were methylated at a level comparable to that
observed in mature oocytes and spermatocytes (fig. 1).
These results suggest that the methylation observed in
oocytes is probably established prior to the first meiotic
division.
At present, the hemophilia A database (Wacey et al.
1996) contains 272 mutations at CpGs, 95 of which are
confined to CpGs analyzed in our study (fig. 1). When
the overall methylation levels are compared with the
occurrence of mutations, no obvious correlation be-
tween degree of methylation and frequency of mutations
can be detected; that is, mutational hot spots apparently
do not coincide with sites of preferential methylation.
However, since, for most of these sites, such an effect
might be masked by different phenotypes of the disease
(e.g., by a possible founder effect of some mutations or
regions within the factor VIII gene that bear less signif-
icance for protein function, or by a certain bias in the
screening methods for mutations), we concentrated on
the analysis of a subgroup of hot spots. All CpG mu-
tations at these hot spots (codons 427, 1696, 1941,
1966, and 2163) create uniform nonsense mutations
leading to phenotypically comparable cases of severe he-
mophilia. Yet, even in this group, no significant corre-
lation between methylation levels and number of mu-
tational events was observed.
Discussion
It is widely accepted that point mutations originate
more often in male than in female germ cells, thereby
providing a rationale for the concept of male-driven ev-
olution (Shimmin et al. 1993; Becker et al. 1996; Elle-
gren and Fridolfsson 1997). At present, the role of sex-
biased methylation in sex-specific mutation rates is being
widely discussed. However, no direct proof for any of
the proposed mechanisms has been provided until now
(Sapienza 1996; Crow 1997).
To address this issue, we established a detailed meth-
ylation map of CpG dinucleotides within the factor VIII
and FGFR3 genes in mature male and female gametes
(fig. 1). These genes have been chosen because of the
following reasons: The X-linked factor VIII gene dis-
plays a higher mutation rate in the male germ line, and
CpG positions are affected in ∼40% of all point mu-
tations (Youssoufian et al. 1986; Pattinson et al. 1990).
In the autosomal FGFR3 gene, a GrA transition within
a CpG site at codon 380 is the cause of 95% of all cases
of achondroplasia (Rousseau et al. 1994; Bellus et al.
1995). Moreover, a striking paternal-age effect has been
described, suggesting an almost exclusive paternal origin
of the causal mutation in achondroplasia (Rousseau et
al. 1994; Orioli et al. 1995).
Our study presents the first detailed methylation pro-
files of human disease genes in mature germ cells. Anal-
ysis of 33 CpG sites in mature spermatocytes and of 27
CpG sites in mature oocytes revealed a high degree of
similarity in methylation levels of male and female
gametes.
This overall high level of methylation at CpG sites in
germ cells supports the molecular link between meth-
ylation and hypermutability (Cooper and Youssoufian
1988). However, the observation of equal levels of meth-
ylation in the sexes contradicts conclusions drawn from
previous studies. Driscoll and Migeon (1990) investi-
gated the methylation pattern in single-copy genes of
cell populations taken from human fetal ovaries and fetal
testes. They found that, prior to the onset of meiosis,
primordial germ cells were unmethylated in both sexes,
and data on meiotic fetal ovary cells suggested that fe-
male germ cells remain unmethylated during oogenesis.
In contrast, male germ cells became methylated post-
natally, prior to or during the early stages of spermato-
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genesis. However, Driscoll and Migeon provide no data
on oocytes at the time of fertilization, and thus the pos-
sibility remains that mature germ cells are methylated
de novo during late stages of their ontogeny. Our study
is the first to address this subject in humans and clearly
supports this hypothesis. Furthermore, It is in accor-
dance with a study on murine mature oocytes and sper-
matocytes (Kafri et al. 1992), which showed CpG sites
of single-copy genes to be methylated in mature germ
cells from both sexes. In the case of the mouse, the onset
of methylation occurs in both male and female germ
cells during days 15.5 and 18.5 of development. Al-
though the exact time at onset of germ-line–specific
methylation remains to be determined in humans, our
results on methylation in the first polar bodies indicate
that, in humans, too, methylation may be established
prior to the first meiotic division.
Overall, our results argue against previous models,
which propose that the observed sex bias in de novo
mutation rates might be a simple reflection of sex-specific
methylation differences. It follows that the origin of sex-
biased CpG mutation rates must be sought in either (i)
the different time at onset of methylation in female ver-
sus male germ line, (ii) the different cellular environ-
ments of the female versus the male germ line, which
may influence the rate of spontaneous deamination of
methyl cytosines, or (iii) the vastly different cycles of
DNA replications in female versus male germ cells. On
the basis of our results, we favor the third explanation
as being the most plausible. In human females, a con-
stant number of divisions—that is, 24—occur during
oogenesis, whereas the number of divisions during male
gametogenesis reaches ∼400 in a 30-year-old male and
increases continuously with age (Crow 1997; Vogel and
Motulsky 1997). As an explanation for the phenomenon
of male-driven evolution, the greater number of mitotic
divisions in the male germ line is more plausibly sup-
ported by our data than is the hypothesis of different
methylation levels. Methylation definitely contributes to
this effect, by creating hot spots for mutations at
CpGs—mutations that, although occurring at equal
rates in both germ lines, are, as a consequence of higher
replication rates, fixed at a higher proportion in the male
germ line.
In the hemophilia A database, the number of mutation
events reported at the CpG sites investigated in this study
is very heterogeneous, with a range of 0–19 (Wacey et
al.1996). When these mutation frequencies are com-
pared with the observed CpG methylation levels, no ob-
vious correlation can be detected; that is, themethylation
is not significantly higher at CpGs that exhibit a higher
mutation rate. This becomes particularly obvious in a
comparison of five mutational hot spots (at codons 427,
1696, 1941, 1966, and 2163), in which a CrT transition
creates stop codons, which lead to a rather uniform and
severe phenotype of the disease. Therefore, a simple sce-
nario is not capable of explaining similar mutation rates
at CpG codons with very different methylation levels
within one of the sexes (fig. 1), an effect that has also
been observed for p53 mutations in lung cancer cells
(Denissenko et al. 1997). Since the efficiency of mutation
fixation through DNA replication should be identical
for all sites, differential methylation should be correlated
with the mutation rate. We can invoke only three pos-
sible mechanisms for this discrepancy. First, the meth-
ylation status may not have any significant influence on
the mutation rate. Given the host of available data sup-
porting CpG mutability, this seems unlikely. Second, ad-
ditional factors may influence the rate of deamination
more or less site specifically. This may be mediated by
preferential binding and interaction of exogenous chem-
icals with sequence-specific targets of DNA sequences,
as is the preferential interaction of (/)anti–7b,8a-dih-
ydroxy-9a,10a-epoxy-7,8,9,10-tetrahydrobenzopyrene
(BPDE) to methylated CpG at codons 175, 248, and 273
of the p53 gene (Denissenko et al. 1997). However, how
these adduct formations may influence the mutagenicity
of theses methylated CpG sites is not known yet.
Third—and, in our view, most convincingly—the effi-
ciency of repair could be somewhat biased with regard
to either sequence context or chromatin structural con-
text of the affected sites.
The overall high methylation at all CpGs analyzed
also raises the question of why a relatively high density
of methylation is maintained in both genes, despite the
fact that a considerable number of these CpG sites, in
which a CrT transition would create only a conservative
amino acid exchange, are evolutionarily maintained.
This observation might indicate that a certain density of
methylation must be maintained in both genes—to en-
sure either the structural integrity or the proper regu-
lation of the genes.
One remarkable observation of our study concerns
the significantly lower rate of methylation in region B
(exon 14 of the factor VIII gene), compared with that
in the other regions investigated. Such regional hypo-
methylation,which also has been reported for exon 25
of the retinoblastoma gene (Mancini et al. 1997), might
be linked to specific features of DNA sequence and/or
chromatin structure and may have some importance for
transcription regulation of these genes. Exon 14 codes
for the B domain, which constitutes ∼40% of the mature
factor VIII protein (Vehar et al. 1984; Toole et al. 1984).
During activation by thrombin, the B-domain is com-
pletely removed from the protein (Kaufman 1992). Sev-
eral studies have shown that the B-domain is not nec-
essary for factor VIII function (Eaton et al. 1986; Toole
et al. 1986). A recombinant B-domain–deleted factor
VIII protein has already been successfully given to he-
mophilia A patients in a phase 3 clinical trial (Fijna-
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vandraat et al. 1997). Although the function of the B-
domain has not yet been elucidated, it is conceivable
that both exon 14 (at the DNA level) and the B-domain
(at the protein level) are involved in the regulation of
factor VIII expression (Pittman et al. 1994). Further
studies are needed to evaluate whether hypomethylation
of exon 14 is in fact related to a regulatory role of this
region in the expression of the factor VIII gene product.
In conclusion, the present study provides evidence for
closely similar methylation rates at noncluster CpGs in
mature germ cells of both sexes and thus implies that
the greater number of mitotic divisions—rather than a
sex-specific methylation effect—is the decisive factor
that accounts for the higher mutability of the male germ
line.
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